By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Dr Rangan Chatterjee"This Is Feeding Cancer Cells!" - Fix This To Starve Disease & Heal The Body | Thomas Seyfried
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
Great conversations run long. Their best ideas don't have to.
uListen is free on iPhone, iPad, Android, Chrome, and Claude.
See howCHAPTERS
Chapter summaries
Why Cancer Rates Are Rising: Diet, Lifestyle and Metabolic Disease
Rangan Chatterjee opens with the rise in lifetime cancer risk and asks Thomas Seyfried what is going on. Seyfried points to Western diet and lifestyle, obesity, and a shared trajectory with type 2 diabetes and Alzheimer's, and links them through mitochondria and metabolic homeostasis.
- •Seyfried says no single factor explains the rise, but Western diet, contaminants, low exercise and high-carbohydrate foods are central
- •Obesity is replacing smoking as a major risk factor for cancer
- •Cancer, type 2 diabetes and Alzheimer's are on a similar upward trajectory
- •Seyfried ties these diseases to loss of metabolic homeostasis and dysfunctional mitochondria
Cancer in Traditional Populations and the Body's Resistance
Chatterjee asks whether cancer was really absent in indigenous groups. Seyfried cites Albert Schweitzer's examinations and the Inuit experience, and uses a monkey carcinogen study to argue that the body resists cancer until diet and lifestyle break that resistance down.
- •Schweitzer examined 40,000 Africans living traditionally and found no cancer
- •The Inuit now suffer diabetes, cancer and dementia that their ancestors did not
- •Monkeys exposed to a carcinogen for years did not develop cancer on their natural diet
- •Chatterjee frames building a buffer through healthy habits as the way to resist modern exposures
How Cancer Develops: Mitochondrial Damage and Fermentation
Responding to Chatterjee's comparison with type 2 diabetes, Seyfried explains that cancer builds up over time and that diverse causes share one mechanism. Chronic disruption of oxidative phosphorylation in the mitochondria pushes cells back to ancient fermentation. Chatterjee suggests cancer is a symptom of mitochondrial problems, and Seyfried agrees.
- •Many agents (carcinogens, viruses, radiation, inflammation, inherited genes) converge on a common mechanism
- •Chronic, not acute, damage to oxygen-based energy production lets cells survive and ferment
- •Mitochondria also control the cell cycle, so damage lets cells revert to default proliferation
- •Seyfried agrees with Chatterjee that cancer is a symptom of mitochondrial problems
Glucose, Glutamine and the Press-Pulse Strategy
Seyfried explains that cancer cells ferment glucose and glutamine but cannot use ketones or fatty acids. The solution is to target fermentation while shifting normal cells to ketones. Because glutamine matters to normal physiology, he describes pairing diet with repurposed drugs in a pulsed way.
- •Glucose transporters are upregulated on cancer cells, which is why PET scans detect tumors
- •Glutamine is the second major fermentable fuel
- •Fatty acids and ketones cannot be used by tumor cells but can by normal cells
- •The Press-Pulse strategy combines low glucose and high ketones with pulsed glutamine-targeting drugs
Aerobic vs Anaerobic Energy, Muscle, Liver and Metabolic Flexibility
Chatterjee asks whether cancer's metabolism resembles anaerobic exercise. Seyfried explains lactic acid in sprinting and the Cori cycle, how muscle hoards glucose while the liver shares glycogen with the brain, and how ketones take over after fasting. He contrasts this flexibility with the cancer cell, which is trapped in fermentation.
- •Sprinting uses anaerobic energy and dumps lactic acid, which the liver converts back into glucose
- •Muscle keeps its glycogen for itself, while liver glycogen supplies the brain
- •After about 36 hours without food, fat is mobilized and the liver makes ketones for the brain
- •Cancer cells lack this flexibility and are limited to fermentation
Cancer Cells as a Return to Ancient Energy Metabolism
Chatterjee asks whether the cancer cell is reverting to a more primitive form of energy production. Seyfried says cancer cells are not equivalent to pre-oxygen cells but share their fermentation and unrestrained growth. He describes mitochondria as a symbiotic fusion that made multicellular life possible and says cancer dies once fermentable fuels are removed.
- •Pre-oxygen cells fermented and proliferated until fuels ran out; cancer cells behave similarly
- •Mitochondria arose from a fusion of two organisms, enabling multicellularity
- •Cancer cells look primitive and undifferentiated under the microscope
- •Management means restricting fermentable fuels so normal cells outcompete the tumor
Genes, BRCA1 and Somatic Mutations as Downstream Effects
Chatterjee asks where genetics fits, including BRCA1/2. Seyfried describes the somatic mutation theory, argues inherited mutations are secondary risk factors that damage mitochondria, and says somatic mutations largely result from reactive oxygen species. They discuss how protecting mitochondria could lower risk even in carriers.
- •The somatic mutation theory is the dominant view, as stated by the National Cancer Institute
- •Inherited mutations like BRCA1 and p53 affect mitochondria and are risk factors, not 100% determinants
- •Reactive oxygen species from faulty respiration cause the mutations seen in cancer
- •Exercise and ketogenesis protect mitochondria and could reduce risk, though the right studies haven't been done
Informed Consent and the Epilepsy Ketogenic Diet Story
Chatterjee raises informed consent, using epilepsy and ketogenic diets as an example. Seyfried recounts the history of the diet from fasting, its revival through Charlie Abrams, and how his lab moved from epilepsy models to cancer models. He says metabolic therapy for cancer lacks clinical trials because trained people and protocols are not yet in place.
- •Chatterjee argues patients should be told all options, including ketogenic diets for epilepsy
- •Seyfried describes Wilder's 1921 work and the diet's revival after Charlie Abrams
- •His lab saw calorie-restricted diets suppress angiogenesis and tumors in mouse models
- •Epilepsy diets are used only after drugs fail, and he sees the same reversal in cancer
- •A cancer clinical trial awaits a treatment protocol and trained clinicians
Is Every Cancer the Same? A Common Metabolic Target
After Seyfried describes his forty years in cancer research, Chatterjee asks whether all cancers are fundamentally the same. Seyfried says different cancers differ genetically but share mitochondrial abnormalities and dependence on glucose and glutamine fermentation. They then discuss why ketosis is linked to benefits across many diseases and the place of ancestral ketosis.
- •Seyfried explains how most cancer research is not aimed at managing the disease in the clinic
- •He reviewed ultrastructure records and found abnormal mitochondria in all major cancers
- •Tumors look and profile differently but are metabolically similar
- •Ancestral populations were in ketosis and had little chronic disease
- •Seyfried says the state of therapeutic ketosis matters more than any specific ketogenic diet
Radical Remissions, Diet Differences and the Glucose Ketone Index
Chatterjee asks how keto and plant-based success stories fit together. Seyfried cites radical remission accounts and the Cancer Revolution documentary, and introduces the glucose ketone index and a meter to measure it. Chatterjee suggests that changing one's environment can shift cancer's inputs, and Seyfried agrees, especially early on.
- •Radical diet and lifestyle changes may overwhelm tumor cells, which lack flexibility
- •N-of-1 survivor stories exist, but no clinical trials have tested them
- •The glucose ketone index is meant to show when someone reaches metabolic homeostasis, with 2.0 or below putting pressure on cancer
- •Seyfried says acting early with metabolic therapy matters more than after toxic treatments
Combining Metabolic Therapy with Conventional Treatment
Chatterjee and Seyfried agree that metabolic therapy and conventional treatment can be combined. Seyfried says that shrinking tumors metabolically allows lower, more strategic doses of radiation or chemo against survivors that share a common target. They discuss how medical training has not evolved and that oncologists often dismiss the evidence.
- •Seyfried says early toxic treatment weakens normal cells and the body's ability to fight the tumor
- •Metabolic therapy narrows tumor cells so they share a common vulnerability
- •Seyfried cites a group in Istanbul using metabolic therapy with lower conventional doses
- •Chatterjee says his training in 1995 focused on diagnosis and pharmaceuticals and has barely evolved
Measuring GKI and Seyfried's Cancer Protocol
They go deeper on the glucose ketone index. Seyfried explains typical ratios of about 50 in the general population, how fasting lowers them, and his planned sequence of zero-carb diet, water-only fasting and repurposed drugs. He also covers hyperbaric oxygen, weight loss concerns, and the difference between therapeutic and pathological weight loss.
- •Typical GKI is around 50 to 60, and fasting takes it below 1
- •The protocol steps from zero-carb eating to water-only fasting, then adds glutamine-targeting drugs
- •Hyperbaric oxygen is used as an alternative to radiation once in ketosis
- •Seyfried distinguishes pathological weight loss from therapeutic weight loss
- •The GKI cuts across diets and shows whether a given food helps or hurts
Oncology Resistance, Glioblastoma and Pablo Kelly
Chatterjee shares the story of a friend's child with a brain tumor and the oncologist's dismissive response. Seyfried says this reflects a lack of knowledge in oncology, and argues that hyperglycemia accelerates tumor growth and that radiation and steroids raise glucose in glioblastoma. He cites Pablo Kelly, who chose metabolic therapy and has survived almost nine years.
- •Seyfried says oncologists, including at the Mayo Clinic, dismiss the sugar-tumor link despite evidence
- •He says glioblastoma survival has barely changed in 100 years
- •He argues radiation and steroids raise glucose and glutamine in the tumor microenvironment
- •Pablo Kelly refused radiation and chemo and survived nearly nine years after a nine-month prognosis
Sugar, Obesity and Cancer Prevention
Chatterjee asks whether sugar causes cancer, given the need for careful messaging. Seyfried says sugar is not a carcinogen but drives inflammation and obesity, and elevated blood sugar accelerates tumor growth. They discuss food deserts, industry and government influence, and how calorie quantity matters on any diet.
- •Seyfried says sugar is not a carcinogen but is linked to inflammation and obesity
- •Obesity is now a major cancer risk factor, and Seyfried links it to processed carbohydrate intake
- •Chatterjee and Seyfried discuss poverty, food deserts and powerful food and drug industries
- •Both note that amount and type of food matter, illustrated by fast-food examples
Practical Prevention Tips, Intermittent Hypoxia and Hope for the Future
Chatterjee asks for practical steps to reduce cancer risk. Seyfried recommends exercise, cutting high-carbohydrate foods and occasionally checking GKI, and they touch on sleep and stress. They close on intermittent hypoxia and Seyfried's hope that medical education can adopt metabolic strategies.
- •Seyfried emphasizes exercise, fewer high-carbohydrate foods and occasional GKI checks
- •Sleep and stress are acknowledged as important and difficult
- •Intermittent hypoxia, which Warburg emphasized, can be countered with oxygenation and exercise
- •Seyfried is hopeful and notes Warburg's claim that 80% of cancers could be reduced
- •He says the challenge is adoption in clinics and medical schools
